Autologous Tumor Infiltrating Lymphocytes TBio-4101

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs TBio-4101 specifically recognize and kill the patient's tumor cells.

**Synonyms:** - Autologous Selected and Expanded TILs TBio-4101 - Autologous Selected and Expanded Tumor Infiltrating Lymphocytes TBio-4101 - Autologous TILs TBio-4101 - TBio 4101 - TBio-4101 - TBio4101